We assign a fundamental rating of 3 out of 10 to KAPA. KAPA was compared to 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for KAPA as it has an excellent financial health rating, but there are worries on the profitability. KAPA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

KAPA had negative earnings in the past year.
In the past year KAPA has reported a negative cash flow from operations.

1.2 Ratios

Looking at the Return On Assets, with a value of -62.76%, KAPA is in line with its industry, outperforming 40.76% of the companies in the same industry.
The Return On Equity of KAPA (-66.05%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-62.76%
ROE	-66.05%
ROIC	N/A

ROA(3y)-111.42%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KAPA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, KAPA has more shares outstanding
KAPA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

KAPA has an Altman-Z score of 17.12. This indicates that KAPA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of KAPA (17.12) is better than 87.81% of its industry peers.
There is no outstanding debt for KAPA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	17.12

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

KAPA has a Current Ratio of 16.56. This indicates that KAPA is financially healthy and has no problem in meeting its short term obligations.
KAPA has a Current ratio of 16.56. This is amongst the best in the industry. KAPA outperforms 93.33% of its industry peers.
A Quick Ratio of 16.56 indicates that KAPA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 16.56, KAPA belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	16.56
Quick Ratio	16.56

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for KAPA have decreased strongly by -33.55% in the last year.

EPS 1Y (TTM)-33.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%30%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -13.70% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-31.67%

EPS Next 2Y-28.45%

EPS Next 3Y-31.68%

EPS Next 5Y-13.7%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

KAPA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KAPA. No positive earnings are expected for the next year.